|
HU212435B
(en)
|
1990-06-07 |
1996-06-28 |
Sandoz Ag |
Herbicidal compositions containing substituted phthalides and heterocyclic phthalides as active ingredient and process for preparation of their active ingredients.
|
|
WO1995001961A1
(en)
|
1993-07-09 |
1995-01-19 |
Schering Corporation |
Process for the synthesis of azetidinones
|
|
JPH08295646A
(ja)
|
1995-04-26 |
1996-11-12 |
Teijin Ltd |
ビス（ヒドロキシエトキシフェニル）化合物の製造方法
|
|
US6187774B1
(en)
|
1996-03-04 |
2001-02-13 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Fused heterocyclic compounds and pharmaceutical applications thereof
|
|
AU5907898A
(en)
|
1997-01-13 |
1998-08-03 |
Penn State Research Foundation, The |
Asymmetric synthesis and catalysis with chiral heterocyclic compounds
|
|
IT1292461B1
(it)
|
1997-07-03 |
1999-02-08 |
Great Lakes Chemical Italia |
Composti fotocromatici,procedimento per la loro preparazione e loro utilizzo in materiali polimerici
|
|
US6927214B1
(en)
|
1999-01-15 |
2005-08-09 |
Novo Nordisk A/S |
Non-peptide GLP-1 agonists
|
|
EP1237547A2
(en)
|
1999-07-09 |
2002-09-11 |
Isis Innovation Limited |
Compounds for inhibiting diseases and preparing cells for transplantation
|
|
WO2002046164A1
(en)
|
2000-12-07 |
2002-06-13 |
Astrazeneca Ab |
Therapeutic compounds
|
|
BR0116468A
(pt)
|
2000-12-08 |
2004-06-29 |
Ortho Mcneil Pharm Inc |
Compostos de pirrolina substituìda por indazolila como inibidores de cinase
|
|
WO2003000682A1
(en)
|
2001-06-25 |
2003-01-03 |
Merck & Co., Inc. |
(pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds
|
|
UA74912C2
(en)
*
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
|
US7192939B2
(en)
|
2002-01-30 |
2007-03-20 |
Montana State University |
Pestalotiopsis microsporia isolates and compounds derived therefrom
|
|
KR20050043967A
(ko)
|
2002-09-17 |
2005-05-11 |
액테리온 파마슈티칼 리미티드 |
1-피리딘-4-일-요소 유도체
|
|
US20040259179A1
(en)
|
2003-05-30 |
2004-12-23 |
Gerd Assmann |
Sterol markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease
|
|
ES2319539T3
(es)
|
2003-09-17 |
2009-05-08 |
Janssen Pharmaceutica Nv |
Compuestos heterociclicos condensados como moduladores del receptor de serotonina.
|
|
US7371759B2
(en)
|
2003-09-25 |
2008-05-13 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
|
WO2005066136A1
(en)
|
2003-12-22 |
2005-07-21 |
Eli Lilly And Company |
Bicyclic derivatives as ppar modulators
|
|
WO2005112932A2
(en)
|
2004-05-07 |
2005-12-01 |
Exelixis, Inc. |
Raf modulators and methods of use
|
|
WO2005121138A2
(en)
|
2004-06-03 |
2005-12-22 |
Rigel Pharmaceuticals, Inc. |
Heterotricyclic compounds for use as hcv inhibitors
|
|
GB0419481D0
(en)
|
2004-09-02 |
2004-10-06 |
Cancer Rec Tech Ltd |
Isoindolin-1-one derivatives
|
|
WO2006034419A2
(en)
|
2004-09-21 |
2006-03-30 |
Athersys, Inc. |
Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof
|
|
EP2298295B1
(en)
|
2005-01-31 |
2013-08-28 |
Cephalon, Inc. |
Tumor necrosis factor inhibitors
|
|
US20090305964A1
(en)
|
2005-04-21 |
2009-12-10 |
Gastrotech Pharma A/S |
Pharmaceutical preparations of a glp-1 molecule and an anti-emetic drug
|
|
WO2007009883A1
(en)
|
2005-07-15 |
2007-01-25 |
F. Hoffmann-La Roche Ag |
Novel heteroaryl fused cyclic amines
|
|
SI1931660T1
(sl)
|
2005-09-29 |
2012-12-31 |
Sanofi |
Derivati fenil-(1,2,4)-oksadiazol-5-ona s fenilno skupino, postopki za njihovo pripravo in njihova uporaba kot zdravila
|
|
JP4955009B2
(ja)
|
2005-11-11 |
2012-06-20 |
エフ．ホフマン−ラ ロシュ アーゲー |
凝固因子Ｘａの阻害剤としての炭素環式縮合環アミン
|
|
EP1986643A1
(en)
|
2006-02-10 |
2008-11-05 |
Summit Corporation Plc |
Treatment of duchenne muscular dystrophy
|
|
EP2046333A4
(en)
|
2006-07-24 |
2010-09-15 |
Glaxosmithkline Llc |
THIOZOLIDINEDIONE DERIVATIVES AS INHIBITORS OF P13-KINASE
|
|
EP2091921A2
(en)
|
2006-11-03 |
2009-08-26 |
Glenmark Pharmaceuticals S.A. |
Bridged bicyclic indazoles as cannabinoid receptor ligands
|
|
US20130012485A1
(en)
|
2006-12-22 |
2013-01-10 |
Baeschlin Daniel Kaspar |
Organic compounds
|
|
GB0706072D0
(en)
|
2007-03-28 |
2007-05-09 |
Sterix Ltd |
Compound
|
|
CA2684633A1
(en)
|
2007-04-20 |
2008-10-30 |
Schering Corporation |
Pyrimidinone derivatives and methods of use thereof
|
|
GB0715087D0
(en)
|
2007-08-03 |
2007-09-12 |
Summit Corp Plc |
Drug combinations for the treatment of duchenne muscular dystrophy
|
|
WO2009036275A1
(en)
|
2007-09-13 |
2009-03-19 |
Link Medicine Corporation |
Treatment of neurodegenerative diseases using indatraline analogs
|
|
WO2009099736A2
(en)
|
2008-02-06 |
2009-08-13 |
Lead Therapeutics, Inc. |
Benzoxazole carboxamide inhibitors of poly(adp-ribose)polymerase (parp)
|
|
CA2721060A1
(en)
|
2008-04-09 |
2009-10-15 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
|
US8735391B2
(en)
|
2008-09-26 |
2014-05-27 |
University Of Kansas |
Synthesis of functionalized octahydro-isoquinolin-1-one-8-carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods
|
|
AR075051A1
(es)
|
2009-02-05 |
2011-03-02 |
Schering Corp |
Compuestos antidiabeticos que contienen ftalazina
|
|
US8455516B2
(en)
|
2010-01-15 |
2013-06-04 |
Touro University |
HIV-1 fusion inhibitors and methods
|
|
JP2013530963A
(ja)
|
2010-06-09 |
2013-08-01 |
レセプトス インコーポレイテッド |
新規のｇｌｐ−１受容体安定化薬および調節薬
|
|
WO2012065065A1
(en)
|
2010-11-12 |
2012-05-18 |
Follica, Inc. |
Methods and compositions for modulating hair growth, wound healing and scar revision
|
|
EP2640373A4
(en)
|
2010-11-16 |
2014-04-23 |
Univ New Jersey Med |
TREATMENT OF TYPE II DIABETES AND DIABETES ASSOCIATED DISEASES WITH SAFE CHEMICAL MITOCHONDRIENE COPPERS
|
|
JP5805982B2
(ja)
|
2011-04-20 |
2015-11-10 |
ユニチカ株式会社 |
ポリアリレート樹脂フィルムおよび気体分離膜
|
|
JP5687120B2
(ja)
|
2011-04-20 |
2015-03-18 |
ユニチカ株式会社 |
ポリアリレート樹脂
|
|
KR101401705B1
(ko)
|
2012-01-31 |
2014-06-27 |
울산대학교 산학협력단 |
로듐 촉매를 이용한 이소인돌린 유도체의 합성방법
|
|
WO2013151975A1
(en)
|
2012-04-02 |
2013-10-10 |
Northeastern University |
Compositions and methods for the inhibition of methyltransferases
|
|
US20150272939A1
(en)
|
2012-10-02 |
2015-10-01 |
Yale University |
Identification of Small Molecule Inhibitors of Jumonji AT-Rich Interactive Domain 1A (JARID1A) and 1B (JARID1B) Histone Demethylase
|
|
WO2014101120A1
(en)
|
2012-12-28 |
2014-07-03 |
Merck Sharp & Dohme Corp. |
Heterobicyclo-substituted-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with a2a antagonist properties
|
|
JP6314335B2
(ja)
|
2013-02-06 |
2018-04-25 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新しいインダニルオキシジヒドロベンゾフラニル酢酸
|
|
NZ708593A
(en)
|
2013-02-27 |
2018-01-26 |
Mochida Pharm Co Ltd |
Novel pyrazole derivative
|
|
PL3022210T3
(pl)
|
2013-07-17 |
2018-08-31 |
Boehringer Ingelheim International Gmbh |
Nowy pochodne azabenzimidazolu
|
|
CN103421006B
(zh)
|
2013-08-18 |
2016-06-22 |
上海师范大学 |
2,3,5,7-四取代二氢吡唑并六氢吡啶衍生物及其制备方法和应用
|
|
EP2857550A1
(en)
|
2013-10-02 |
2015-04-08 |
Basf Se |
Amine precursors for depositing graphene
|
|
AR098215A1
(es)
|
2013-10-29 |
2016-05-18 |
Takeda Pharmaceuticals Co |
Compuesto heterocíclico
|
|
TW201625605A
(zh)
|
2014-04-04 |
2016-07-16 |
賽諾菲公司 |
用於治療糖尿病、肥胖、血脂異常及相關病症之作為ｇｐｒ１１９調節劑的經取代之稠合雜環類
|
|
EP2993174A1
(en)
|
2014-09-08 |
2016-03-09 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH |
Pyrazolopyridine derivatives and their use in therapy
|
|
CN105646459A
(zh)
|
2014-11-13 |
2016-06-08 |
上海和辉光电有限公司 |
一种化合物及其制备方法和应用
|
|
WO2016118639A1
(en)
|
2015-01-20 |
2016-07-28 |
The Trustees Of Columbia University In The City Of New York |
Small molecule oxidizers of pdi and their use
|
|
WO2017182983A1
(en)
|
2016-04-22 |
2017-10-26 |
Sabic Global Technologies B.V. |
Methods of manufacture of 2-aryl-3,3-bis(hydroxyaryl)phthalimidines
|
|
WO2017182986A1
(en)
|
2016-04-22 |
2017-10-26 |
Sabic Global Technologies B.V. |
Methods of manufacture of 2-aryl-3,3-bis(hydroxyaryl)phthalimidines
|
|
WO2017182984A1
(en)
|
2016-04-22 |
2017-10-26 |
Sabic Global Technologies B.V. |
Methods of manufacture of 2-aryl-3,3-bis (4-hydroxyaryl) phthalimidines, and polymers derived therefrom
|
|
JOP20190060A1
(ar)
|
2016-09-26 |
2019-03-26 |
Chugai Pharmaceutical Co Ltd |
مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1
|
|
WO2018106818A1
(en)
|
2016-12-07 |
2018-06-14 |
Kura Oncology, Inc. |
Methods of promoting beta cell proliferation
|
|
KR102314286B1
(ko)
|
2016-12-16 |
2021-10-21 |
화이자 인코포레이티드 |
Glp-1 수용체 작용제 및 이의 용도
|
|
EP3600270B1
(en)
|
2017-03-31 |
2023-06-14 |
Aurigene Oncology Limited |
Compounds and compositions for treating hematological disorders
|
|
TWI782056B
(zh)
|
2017-07-14 |
2022-11-01 |
日商鹽野義製藥股份有限公司 |
具有ｍｇａｔ２抑制活性的縮合環衍生物
|
|
JP7264906B2
(ja)
|
2017-11-01 |
2023-04-25 |
ブリストル－マイヤーズ スクイブ カンパニー |
ファルネソイドｘ受容体モジュレーターとしてのアルケン化合物
|
|
JP7461104B2
(ja)
|
2017-11-29 |
2024-04-03 |
中外製薬株式会社 |
Ｇｌｐ－１受容体アゴニスト作用を持つピラゾロピリジン誘導体を含有する医薬組成物
|
|
WO2019126424A1
(en)
|
2017-12-22 |
2019-06-27 |
Chemocentryx, Inc. |
DIARYL SUBSTITUTED 6,5-FUSED RING COMPOUNDS AS C5aR INHIBITORS
|
|
AR114237A1
(es)
*
|
2018-02-01 |
2020-08-05 |
Japan Tobacco Inc |
Compuesto de amida heterocíclica que contiene nitrógeno y su uso farmacéutico
|
|
MX2020008265A
(es)
|
2018-02-16 |
2020-09-21 |
UCB Biopharma SRL |
Derivados farmaceuticos del anillo heterobiciclico 6,5.
|
|
EP3759110A1
(en)
*
|
2018-02-28 |
2021-01-06 |
Novartis AG |
Indole-2-carbonyl compounds and their use for the treatment of hepatitis b
|
|
US20190284341A1
(en)
|
2018-03-14 |
2019-09-19 |
Sabic Global Technologies B.V. |
3-oxo-2-alkylisoindoline diphthalonitrile monomers, methods of manufacture, thermosetting compositions comprising the same, and uses thereof
|
|
US20190284340A1
(en)
|
2018-03-14 |
2019-09-19 |
SABIC Global Technologies B.V |
3-oxo-2-arylisoindoline diphthalonitrile monomers, methods of manufacture, thermosetting compositions comprising the same, and uses thereof
|
|
BR112020019822A2
(pt)
|
2018-04-02 |
2021-03-16 |
Chemocentryx, Inc. |
Profármacos de antagonistas bicíclicos fundidos de c5ar
|
|
US10934279B2
(en)
|
2018-06-13 |
2021-03-02 |
Pfizer Inc. |
GLP-1 receptor agonists and uses thereof
|
|
DK3806855T5
(da)
|
2018-06-15 |
2023-05-22 |
Pfizer |
GLP-1-receptoragonister og anvendelser deraf
|
|
WO2020001321A1
(en)
|
2018-06-27 |
2020-01-02 |
The Hong Kong Polytechnic University |
Compounds with antimicrobial activity
|
|
US11923622B2
(en)
|
2018-08-02 |
2024-03-05 |
Nokia Solutions And Networks Oy |
Antenna and wireless communication device
|
|
PY1991603A
(es)
*
|
2018-11-02 |
2020-09-17 |
Aicuris Gmbh & Co Kg |
Nueva 6,7-dihidro-4h-pirazolo [1,5-a] pirazina indole -2-carboxamidas activas contra el virus de la hepatitis b (vhb)
|
|
AR117189A1
(es)
|
2018-11-02 |
2021-07-21 |
Aicuris Gmbh & Co Kg |
Derivados de 6,7-dihidro-4h-pirazolo[1,5-a]pirazin indol-2-carboxamidas activos contra el virus de la hepatitis b (vhb)
|
|
MA54555A
(fr)
|
2018-11-22 |
2021-09-29 |
Qilu Regor Therapeutics Inc |
Agonistes de glp-1r et leurs utilisations
|
|
CN111217796B
(zh)
|
2018-11-26 |
2021-12-14 |
上海亚舸生物科技有限公司 |
一类螺环-二吡咯甲烷/二吡咯甲川化合物及其制备方法和应用
|
|
CN111217842B
(zh)
|
2018-11-26 |
2023-01-31 |
上海亚舸生物科技有限公司 |
一类螺环-二吡咯甲烷硼配合物/二吡咯甲川硼配合物及其制备方法和应用
|
|
US20220204473A1
(en)
|
2018-12-25 |
2022-06-30 |
Shanghai Meiyue Biotech Development Co., Ltd. |
Compound as irak inhibitor
|
|
WO2020163236A1
(en)
|
2019-02-04 |
2020-08-13 |
The General Hospital Corporation |
Treating long qt syndrome
|
|
CA3132531A1
(en)
|
2019-03-14 |
2020-09-17 |
Janssen Sciences Ireland Unlimited Company |
Fused ring pyrimidone derivatives for use in the treatment of hbv infection or of hbv-induced diseases
|
|
EP3953344A4
(en)
|
2019-04-12 |
2023-08-09 |
Qilu Regor Therapeutics Inc. |
GLP-IR AGONISTS AND THEIR USES
|
|
TWI751585B
(zh)
|
2019-06-28 |
2022-01-01 |
美商美國禮來大藥廠 |
類升糖素肽1受體促效劑
|
|
WO2021018023A1
(zh)
|
2019-08-01 |
2021-02-04 |
济南泰达领创医药技术有限公司 |
小分子glp-1受体调节剂
|
|
CN110804059B
(zh)
|
2019-09-30 |
2024-03-12 |
郑州泰基鸿诺医药股份有限公司 |
氨基甲酸酯类化合物、药物组合物及其应用
|
|
EP4048664A1
(en)
|
2019-10-25 |
2022-08-31 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
WO2021096284A1
(ko)
|
2019-11-15 |
2021-05-20 |
일동제약(주) |
Glp-1 수용체 작용제 및 이의 용도
|
|
HRP20241159T1
(hr)
|
2020-02-07 |
2024-12-06 |
Gasherbrum Bio, Inc. |
Heterociklički agonisti za glp-1
|
|
JP7836762B2
(ja)
|
2020-02-13 |
2026-03-27 |
ガシャーブラム・バイオ・インコーポレイテッド |
ヘテロ環ｇｌｐ－１アゴニスト
|
|
TW202206429A
(zh)
|
2020-04-29 |
2022-02-16 |
美商迦舒布魯姆生物有限公司 |
雜環ｇｌｐ—１促效劑
|
|
US12037339B2
(en)
*
|
2020-07-20 |
2024-07-16 |
Eccogene Inc. |
Substituted imidazoles as GLP-1 receptor agonists
|
|
EP4211133A4
(en)
|
2020-09-07 |
2024-11-27 |
Gasherbrum Bio, Inc. |
HETEROCYCLIC GLP-1 AGONISTS
|
|
TW202227435A
(zh)
|
2020-09-11 |
2022-07-16 |
愛爾蘭商健生科學愛爾蘭無限公司 |
用於治療ｈｂｖ感染或ｈｂｖ誘發的疾病之稠合環嘧啶酮衍生物
|
|
WO2023016546A1
(en)
|
2021-08-12 |
2023-02-16 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
JP2025509281A
(ja)
|
2022-03-09 |
2025-04-11 |
ガシャーブラム・バイオ・インコーポレイテッド |
ヘテロ環式ｇｌｐ－１アゴニスト
|
|
TW202435857A
(zh)
|
2022-12-15 |
2024-09-16 |
美商迦舒布魯姆生物有限公司 |
具有glp-1促效劑活性之化合物之鹽及固體形式
|
|
CN120659776A
(zh)
|
2022-12-19 |
2025-09-16 |
伊莱利利公司 |
Glp1 ra及其中间体的制备方法
|
|
EP4652167A1
(en)
|
2023-01-17 |
2025-11-26 |
Fochon Biosciences, Ltd. |
Glp-1r agonists and uses thereof
|
|
CN120957993A
(zh)
*
|
2023-02-16 |
2025-11-14 |
加舒布鲁姆生物公司 |
杂环glp-1激动剂
|
|
WO2025002250A1
(zh)
|
2023-06-29 |
2025-01-02 |
韦恩生物科技有限公司 |
一种glp-1受体激动剂及其制备方法和用途
|